Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

doripenem

doripenem
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Doribax POWDER FOR INJECTION, INTRAVENOUS 250 mg, 500 mg      
VIEW MORE Carbapenems
CLASS
08120708
Comments:

 Doripenem discontinued by manufacturer as of October 2018.

 

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

Notes

doripenem (Doribax)

  • 500 mg IV q 8 hrs
  • 500 mg IV q 12 hrs
  • 250 mg IV q 8 hrs
  • 250 mg IV q 12 hrs
  • 500 mg IV q 8 hrs

  Hemofiltration/Hemodiafiltration

  • 500 mg IV q 8 hrs

  Hemodialysis

  • 250 mg q 12 hrs (dose after dialysis)

meropenem (Merrem)

  • 1 g IV q 8 hrs
  • 1 g IV q 12 hrs
  • 500 mg IV q 8 hrs
  • 500 mg IV q 12 hrs
  • 1g IV q 8 hrs

   Hemofiltration/Hemodiafiltration

  • 1 g IV q 12 hrs

   Hemodialysis

  • 500 mg IV q 24 hrs (dose after dialysis)

 

at same frequency (except hemofiltration/dialysis - see formulary link)

doripenem is restricted to NO SUB orders and ID, Critical Care(i.e. Pulmonology, Trauma), ED, Pediatrics (Hospitalists, Oncology/St Jude, Critical Care). If a non-approved physician prescribes doripenem, contact the physician to discuss alternative therapy.

Automatic renal adjustment per guidelines. Renal Adjustment Guidelines

Reviewed: January 26, 2010, and June 25, 2013 (Doribax), and 25 May 2017 (Doribax), and 26 Sept 2017 (Doribax)

Last updated: Jun. 7, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved